IndustryIntelligence | Biological Products

The Consus Group provides critical intelligence for the
business, investor, and legal communities.

Documents can be downloaded immediately after purchase. Complete your order by clicking the Add-to-Cart button.

$42	Subscribers Preview	2001	Common Stock Purchase Agreement	Medarex; Seattle Genetics; Venture Law	BofA Securities; CIBC World; J.P. Morgan
$32	Subscribers Preview	2002	Common Stock Purchase Agreement	StemCells, Inc.
$44	Subscribers Preview	2001	Common Stock Purchase Agreement	Sativum Investments Limited; StemCells	Epstein Becker
$42	Subscribers Preview	2003	Common Stock Purchase Agreement	Roth Capital; Targeted Genetic	Orrick; Proskauer Rose
$57	Subscribers Preview	2003	Common Stock Purchase Agreement	Viragen, Inc.	Nasdaq Stock Market Inc.
$40	Subscribers Preview	2001	Common Stock Purchase Agreement	Viragen, Inc.
$47	Subscribers Preview	2000	Common Stock Purchase Agreement	Viragen, Inc.
$63	Subscribers Preview	2001	Common Stock Purchase Agreement [Amended and Restated]	Acqua Wellington North American Equities Fund, Ltd.; CV Therapeutics	Jenkens; Latham & Watkins
$34	Subscribers Preview	2001	Common Stock Purchase Agreement [Amendment No. 1]	Acqua Wellington North American Equities Fund, Ltd.	CV Therapeutics, Inc.
$40	Subscribers Preview	2004	Common Stock Purchase Agreement [Amendment No. 1]	Fusion Capital Fund II, LLC	MicroIslet, Inc.
$35	Subscribers Preview	2000	Compound Purchase Agreement	Allergan; Cephalon; Daiichi Suntory	DPI 2
$45	Subscribers Preview	2001	Compound Purchase Agreement	Allergan; Axys Pharmaceuticals; Cephalon	Daiichi Suntory; DPI; Protein Design
$43	Subscribers Preview	2002	Convertible Note Purchase Agreement	Aventis Pharma; Genta	Morgan Lewis; WSGR
$47	Subscribers Preview	2002	Convertible Note Purchase Agreement	Aventis Pharma; Genta	Morgan Lewis; WSGR
$42	Subscribers Preview	2000	Convertible Note Purchase Agreement	Third Wave Technologies Inc.
$42	Subscribers Preview	2000	International Purchase Agreement	IDEC Pharmaceuticals Corporation; Biogen Idec; Genentech	BofA Securities 2 3 2
$39	Subscribers	2003	Note and Equity Purchase Agreement [Amendment No. 5]	IGI, Inc.	American Capital Strategies Ltd.
$32	Subscribers Preview	2002	Note and Equity Purchase Agreement [Amendment No. 5]	IGI, Inc.	American Capital Strategies Ltd.
$40	Subscribers Preview	2003	Note Purchase Agreement	AVAX Technologies, Inc.
$53	Subscribers Preview	2002	Note Purchase Agreement	Kevin Kimberlin Partners, L.P.; Immune Response	Kirkpatrick; Pillsbury